News for Vita Group Limited (VTG.AX)

Published at

Feb 14, 2025 3:00 PM

by gurufocus.com

mixed

mixed

European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine

PR NewswireWALTHAM, Mass. and SAN DIEGO, Feb. 14, 2025 - KOSTAIVE represents a significant advancement in vaccine technology, demonstrating superior immuno

VTG.AX SFFYF PHPPY CSLLY CSL.AX CMXHF ASXFY ASXFF ARCT TGA.AX

Read more →
Published at

Feb 14, 2025 3:00 PM

by gurufocus.com

mixed

mixed

European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine

Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today announced that the European Commission

VTG.AX SFFYF PHPPY CSLLY CSL.AX CMXHF ASXFY ASXFF ARCT

Read more →
Published at

Sep 25, 2024 10:44 PM

by investing.com

mixed

mixed

CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Fifth BARDA Award in Response to Avian Influenza Outbreak By Investing.com

CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Fifth BARDA Award in Response to Avian Influenza Outbreak

VTG.AX CSLLY CSL.AX CMXHF ASXFY ASXFF TCLCF TCLAF IUSDF

Read more →
Published at

Jul 4, 2024 9:00 AM

by asiaone.com

positive

positive

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe GlobeNewswire July 04, 2024 MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene...

VTG.AX CSL.AX

Read more →
Published at

Apr 30, 2024 3:01 PM

by globenewswire.com

positive

positive

ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA’s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy

CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by...

VTG.AX CSLN.MX CSLLY CSL.AX CMXHF

Read more →
Published at

Aug 28, 2023 2:30 PM

by prnewswire.com

positive

positive

CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine

/PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), was selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the...

VTG.AX CSL.AX

Read more →
Published at

Aug 17, 2023 1:08 PM

by prnewswire.com

positive

positive

CSL Appoints Jeffrey Ball as First Chief Sustainability Officer

/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...

VTG.AX CSLLY CSL.AX APZ.AX

Read more →
Published at

May 10, 2023 5:57 PM

by stockhead.com.au

mixed

mixed

Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?

Telehealth, mental health and aged care stocks rallied on Wednesday following the Budget announcement which include billions for healthcare.

REG.AX ONE.AX LME.AX JHC.AX GLH.AX 1ST.AX RGS.AX PXSLY PXS.AX PBP.AX OCC.AX MEB.AX MDBIF IVX.AX IPDQF IPD.AX IMM.AX HSC.AX CGS.AX ATX.AX ARUXF ADR.AX ACR.AX VTG.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX PGC.AX PCK.AX EYE.AX CMP.AX CAN.AX CAJ.AX BXN.AX AMT.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Apr 3, 2023 7:00 PM

by stockhead.com.au

mixed

mixed

ASX March Winners: Gold stocks the beneficiary in turbulent month for investors

Global markets and ASX show resilience in March as gold stocks the beneficiary of rising gold prices as investors seek safe havens.

VTG.AX VN8.AX TZLTF TZL.AX SRY.AX SCU.AX SBNYP SBNY34.SA SBNY.MX SBNY RXL.AX RNX.AX PAB.AX OSL.AX MME.AX MIN.AX MDX.AX MBK.AX IHR.AX GWR.AX DXN.AX CBR.AX AFL.AX 0A85.L SRJ.AX RSG.AX RLG.AX RHY.AX RBR.AX OAR.AX NVU.AX NCR.AX MKG.AX IPDQF IPD.AX ICNOF ICN.AX ICG.AX HMX.AX GPR.AX FFF.AX 3DA.AX WGX.AX WEC.AX SZL.AX SVL.AX SLVMF SEZNL RMS.AX RCL.AX MXO.AX MRR.AX JPR.AX IME.AX DTR.AX AGY.AX AGG.AX AD1.AX

Read more →
Published at

Mar 27, 2023 9:30 PM

by prnewswire.com

mixed

mixed

CSL Opens New, State-of-the-Art Vaccine Research and Development Facility in Waltham, Massachusetts

/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL; USOTC:CSLLY) today celebrated the official opening of the company's new state-of-the-art research...

VTG.AX CSL.AX TGA.AX

Read more →
Published at

Mar 19, 2023 7:50 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

The hydrogen players tackling a hidden emissions crisis, why one expert loves Domain, and our day trader's in the doghouse... again.

ZNO.AX WBE.AX VTG.AX STN.AX SIX.AX RXL.AX PKD.AX NGY.AX MBK.AX KCN.AX IME.AX IHR.AX GWR.AX FRDSF FGL.AX DXN.AX AOU.AX AGG.AX 4DS.AX WGX.AX VPR.AX RSG.AX OSX.AX MMI.AX TD1.AX SIH.AX RMS.AX QHL.AX PKO.AX PHL.AX OSL.AX MXO.AX MME.AX LSR.AX KEY.AX HIL.AX HFY.AX FIN.AX FIJ.AX EX1.AX ENX.AX CYL.AX CLA.AX BUGLF BNOEF BNO.AX BLG.AX BAS.AX AVW.AX ARV.AX

Read more →
Published at

Mar 17, 2023 6:53 AM

by stockhead.com.au

mixed

mixed

ASX Weekly Small Caps and IPO Wrap: Better stick this one in next door’s bin, it stinks

ASX Weekly Small Caps and IPO Wrap: Better stick this one in next door’s bin, it stinks

ZNO.AX WBE.AX VTG.AX STN.AX SIX.AX RSG.AX PKD.AX NGY.AX MBK.AX KCN.AX IHR.AX GWR.AX FRDSF FGL.AX DXN.AX 4DS.AX WGX.AX VPR.AX OSX.AX MMI.AX IME.AX AGG.AX TD1.AX SIH.AX RXL.AX RMS.AX QHL.AX PKO.AX PHL.AX OSL.AX MXO.AX MME.AX KEY.AX HFY.AX FIN.AX FIJ.AX EX1.AX ENX.AX CYL.AX BUGLF BNOEF BNO.AX BLG.AX BAS.AX AVW.AX ARV.AX

Read more →
Published at

Mar 15, 2023 9:00 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: Everything you need to know before the ASX opens

On Stockhead today, Taylor Collison is backing Genetic Signatures (ASX:GSS) to Outperform saying the medtech's PT could triple.

VTG.AX VRC.AX SIX.AX RLG.AX RKN.AX PYR.AX PRS.AX NTI.AX NCZ.AX MNS.AX MMI.AX MCT.AX GSS.AX ENX.AX EGY.AX CR9.AX CLE.AX APC.AX WRM.AX VAL.AX TD1.AX SRJ.AX PVS.AX POL.AX OPL.AX MCM.AX LCY.AX ICR.AX GWR.AX CPT.AX AKN.AX TKL.AX OLI.AX MXO.AX MTH.AX KEY.AX GTG.AX

Read more →
Published at

Mar 15, 2023 7:10 AM

by stockhead.com.au

mixed

mixed

CLOSING BELL: $368bn AUKUS subs ‘worst deal in history’ says Paul ‘22% mortgage rates’ Keating

The ASX 200 finished 0.89% higher, XEC Emerging Companies is up 1.26%, Vita Group's added 75% and Keating's had a memory lapse for the ages.

VTG.AX VRC.AX TER.AX SIX.AX RLG.AX PYR.AX PRS.AX NTI.AX NCZ.AX MNS.AX MMI.AX MLWEL.PA MLKRI.PA MLAHC.PA MCT.AX ID8.AX ENX.AX EGY.AX CY5.AX CR9.AX CLE.AX APC.AX WRM.AX VAL.AX TD1.AX SRJ.AX PVS.AX POL.AX OPL.AX MCM.AX LCY.AX ICR.AX GWR.AX CPT.AX TKL.AX OLI.AX MXO.AX MTH.AX KMT.AX KEY.AX GTG.AX AKN.AX

Read more →
Published at

Mar 15, 2023 3:44 AM

by stockhead.com.au

mixed

mixed

ASX Small Caps Lunch Wrap: Who else was a little pressed for time this morning?

The ASX has staged The Recovery We Had To Have this morning, but the lukewarm +0.3% was waaay behind Vita Group's ball-busting 72% screamer.

VTG.AX TKL.AX TD1.AX TASEF TAS.AX SRJ.AX SOP.AX OPL.AX OLI.AX MTH.AX KEY.AX G88.AX CY5.AX CLE.AX BOC.AX ADR.AX RIE.AX ODM.AX NEU.AX MBK.AX GWR.AX GLL.AX FAU.AX BTN.AX RHY.AX CYL.AX

Read more →
Published at

Mar 5, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger

Colossal Biosciences’ plans to bring the Tasmanian tiger and woolly mammoth back to life, but now it’s also betting on the iconic dodo.

TD1.AX RGS.AX RAC.AX FFC.AX EZL.AX PYC.AX PAB.AX OPT.AX OPT MX1.AX CMP.AX CKDXF AMT.AX VTG.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX PXSLY PXS.AX PSQ.AX PNV.AX PGC.AX PBP.AX ONE.AX OCC.AX NYR.AX NC6.AX MVF.AX MEM.AX MEB.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMM.AX HCT.AX GTG.AX GSS.AX EYE.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX ATX.AX ARUXF AMDHF ADR.AX ACR.AX

Read more →
Published at

Feb 1, 2023 5:46 PM

by stockhead.com.au

mixed

mixed

Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

PYC.AX PSQ.AX PGC.AX MSB.AX KZA.AX EYE.AX DVL.AX CAN.AX BXN.AX BNOEF BNO.AX ADO.AX SOMNF SOM.AX RSH.AX RHT.AX RGS.AX OSX.AX OSL.AX ONE.AX OIL.AX NXSCF NXS.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IUGNF IMU.AX IDT.AX GLH.AX CYP.AX CMP.AX CAJ.AX AT1.AX ADR.AX 1ST.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SCU.AX RNO.AX RHY.AX RAC.AX PXSLY PXS.AX PNV.AX PCK.AX PBP.AX PAB.AX OVN.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MDR.AX LBT.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GTG.AX GSS.AX FDMDF DXB.AX CPH.AX CKDXF CGS.AX CALZF BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX AMDHF ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Jan 19, 2023 5:50 PM

by stockhead.com.au

mixed

mixed

Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI Inc says it is on a mission to halve the world's blindness with its smartphone-based device.

ZNO.AX ZLD.AX RAP.AX PSQ.AX PIQ.AX PBP.AX PAA.AX MXC.AX IPDQF IPD.AX IDT.AX GLH.AX CGS.AX BXN.AX 1AD.AX SOMNF SOM.AX SHL.AX RSH.AX RGS.AX PGC.AX PCK.AX OVN.AX OSX.AX OSL.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDC.AX LBT.AX KZIA KZA.AX KMLXF IVX.AX IMMP IMM.AX IHL.AX GSS.AX FDMDF DVL.AX CYP.AX CPH.AX CAN.AX BWXXF BWX.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX AT1.AX ARX.AX AKU.TO AKU ADR.AX 4DX.AX 1ST.AX VTG.AX VLS.AX UBI.AX SCU.AX RNO.AX RHY.AX RHT.AX RAC.AX PYC.AX PXSLY PXS.AX PNV.AX PAB.AX OPT.AX OPT ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MVF.AX MEM.AX MEB.AX MDR.AX MDBIF IUGNF IMU.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX EYE.AX DXB.AX CMP.AX CKDXF CALZF CAJ.AX ATX.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX

Read more →
Published at

Jan 4, 2023 6:02 PM

by stockhead.com.au

mixed

mixed

Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half

Moderna’s stock price rose in late December after the company revealed that a vaccine for melanoma showed encouraging results.

TD1.AX RSH.AX PCK.AX MX1.AX KMLXF DVL.AX CAJ.AX BNOEF BNO.AX ARX.AX ADR.AX 1ST.AX ZNO.AX RHY.AX RAC.AX PYC.AX PSQ.AX PGC.AX OVN.AX OSX.AX ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MDC.AX KZA.AX IPDQF IPD.AX IDT.AX GTG.AX CYP.AX CPH.AX CAN.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ZLD.AX VTG.AX VLS.AX UBI.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX RGS.AX PXSLY PXS.AX PNV.AX PBP.AX PAB.AX OSL.AX OPT.AX OPT OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MVF.AX MEM.AX MDR.AX LBT.AX IVX.AX IUGNF IMU.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GSS.AX GLH.AX FDMDF EYE.AX DXB.AX CMP.AX CKDXF CGS.AX CALZF AT1.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX 4DX.AX 1AD.AX

Read more →